Several studies consistently demonstrate higher NfL levels in patients with neurodegenerative diseases compared to controls, with highest levels found in CJD, ALS, FTLD and MSA, reflecting the aggressive nature of these conditions [66–68]. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.